Bottromycin A2
(Inhibitor for protein synthesis)
Specifications
- Code No. : FNK-00592
- Size: 1 mg
- CAS# : 15005-62-6
- Molecular Formula : C42H62N8O7S
- Molecular Weight : 823.067
- Source : Streptomyces, No. 3668-L2
- Appearance : white powder
- Purity : >80% (HPLC)
- Shipping conditions: Room Temperature
- Long Term Storage : at - 20 °C
- Solubility : Soluble in MeOH, Ether and H2O Insoluble in n-Hexane
Application Notes
Bottromycin A2 is a macrocyclic peptide antibiotic isolated from Streptomyces No. 3668-L2.1-3) Bottromycin A2 shows potent antibacterial activities against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) among other Gram-positive bacteria and mycoplasma. 2,3) The mechanism of action of botromycin A2 is known to inhibit bacterial protein synthesis by binding to the A-site of the ribosome and blocking aminoacyl-tRNA binding. 4,5)
References
- Structures of bottromycins A and B. Nakamura S, Chikaike T, Yonehara H, Umezawa H. J. Antibiot. 1965, 18, 60-61.
- Isolation and characterization of bottromycin A and B. Nakamura S, Chikaike T, Karasawa K, Tanaka N, Yonehara H, Umezawa H. J. Antibiot. 1965, 18, 47-52.
- Structure determination and total synthesis of bottromycin A2: a potent antibiotic against MRSA and VRE. Shimamura H, Gouda H, Nagai K, Hirose T, Ichioka M, Furuya Y, Kobayashi Y, Hirono S, Sunazuka T, Omura S. Angew Chem int Ed Engl. 2009, 48, 914-917.
- Mechanism of protein synthesis inhibition by bottromycin A2: studies with puromycin. Lin YC, Kinoshita T, Tanaka N. J. Antibiot. 1968, 21, 471-476.
- Mode of action of bottromycin A2. Release of aminoacyl- or peptidyl-tRNA from ribosomes. Otaka, T. & A. Kaji J. Biol. Chem. 1976, 251, 2299–2306.
Related Products
| Infection Related |
Name |
Product Code |
Link |
| Anti-HIV-Ⅰ |
Benanomicin A |
FNK-02966 |
 |
| Benanomicin B |
FNK-02968 |
 |
| Anti-MRSA, Anti-VRE |
Bottromycin A2 |
FNK-00592 |
Current Link |
Anti-Gram Positive /
Negative Bacteria |
Althiomycin |
FNK-14660 |
 |
| Cyclamidomycin |
FNK-01541 |
 |
| Negamycin (HCl) |
FNK-14662 |
 |
| Anti-Gram Positive Bacteria |
Bottromycin A2 |
FNK-00592 |
Current Link |
| Anti-Respiratory Infectious Bacteria |
Forphenicinol |
FNK-09637 |
 |
| Acid-Fast Bacillus Growth Suppression |
Minosaminomycin |
FNK-02872 |
 |
| Antifungal |
Benanomicin A |
FNK-02966 |
 |
| Benanomicin B |
FNK-02968 |
 |
| Bacterial Protein Synthesis Inhibitor |
Althiomycin |
FNK-14660 |
 |
| Minosaminomycin |
FNK-02872 |
 |
| Negamycin (HCl) |
FNK-14662 |
 |
Pneumocystis pneumonia
suppression |
Benanomicin A |
FNK-02966 |
 |
Natural macrocyclic compounds from microorganisms:
| Structural classification |
Compound Name |
Chemical Structure |
Property / Biological activity |
Link |
| Bacterial proteins/Inhibition of DNA synthesis |
Aplasmomycin (Sodium Salt) |
 |
Aplasmomycin A Inhibited the growth of gram-positive bacteria including mycobacteria and showed an antimalarial activity in mice infected with Plasmodium berghei. |
 |
| Migrastatin |
 |
Migrastatin inhibited metastasis of human esophageal cancer cells and anchorage-independent growth of human small cell lung carcinoma cells. |
 |
| Macrolactams |
Bisucaberin |
 |
Bisucaberin is a siderophore with iron-affinity and induced concentration dependent macrophage-mediated tumor cell lysis. |
 |
| Cyclic peptides |
Bottromycin A2 |
 |
Bottromycin A2 showed growth inhibitory activity against gram-positive bacteria, MRSA (Methicillin-resistant Staphylococcus aureus), and VRE (Vancomycin-resistant Enterococci). |
Current Link |
| Iturin A-2 |
 |
Iturin A-2 showed the control of damping-off of tomato (a seedling disease) and cytotoxicity to human breast cancer cell line BT-474. |
 |
| Plipastatin A1 |
 |
Plipastatin A1 inhibited phospholipase A2 and induced ISR (induced-systemic-resistance). |
 |
| Phepropeptin A |
 |
Phepropeptin A inhibited proteasomal chymotrypsin-like activity. |
 |
| Phepropeptin B |
 |
Phepropeptin B inhibited proteasomal chymotrypsin-like activity. |
 |
| Phepropeptin C |
 |
Phepropeptin C inhibited proteasomal chymotrypsin-like activity. |
 |
| Phepropeptin D |
 |
Phepropeptin D inhibited proteasomal chymotrypsin-like activity. |
 |
| Cycloalkenes |
Rubratoxin A |
 |
Rubratoxin A inhibited protein phosphatase 2A (PP2A) in a competitive manner. |
 |
